An appropriate selection of a 3d alginate culture model for hepatic Huh-7 cell line encapsulation intended for viral studies

Tissue Engineering - Part A

Volumn 19, Issue 1-2, 2013, Pages 103-113

  Tran, Nhu Mai ^a   Dufresne, Murielle ^a   Duverlie, Gilles ^b   Castelain, Sandrine ^b   Défarge, Christian ^c   Paullier, Patrick ^a   Legallais, Cecile ^a  

^a UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

^c BRGM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3D CULTURE; ALGINATE CULTURE; BIOMIMETIC ENVIRONMENT; CELL POLARITY; CELL VIABILITY; CELLULAR ORGANIZATION; CHANNEL-LIKE STRUCTURES; CULTURE SYSTEMS; CULTURE TIME; DYNAMIC CONDITION; HEPATIC CELLS; HEPATITIS C VIRUS; HEPATOCYTES; HUH-7 CELLS; HUMAN HEPATOMA CELL LINES; IN-VITRO; IN-VIVO; LIVER TISSUE ENGINEERING; LIVER-SPECIFIC FUNCTIONS; POLYMERIC MOLECULES; RELATIVE PERMEABILITY; STRUCTURAL CELL; TARGET APPLICATION;

AGGREGATES; ALGINATE; BIOCOMPATIBILITY; BIOMIMETICS; CALCIUM; CALCIUM CHLORIDE; CELL CULTURE; CELL MEMBRANES; CELL PROLIFERATION; CHEMICAL PROPERTIES; DRUG DELIVERY; GELATION; THREE DIMENSIONAL; THREE DIMENSIONAL COMPUTER GRAPHICS; VIRUSES;

SCAFFOLDS (BIOLOGY);

HEPATITIS C VIRUS;

ALGINIC ACID; GLUCURONIC ACID; HEXURONIC ACID;

ARTICLE; ARTIFICIAL LIVER; BATCH CELL CULTURE; BIOMIMETICS; CELL LINE; CHEMISTRY; CYTOLOGY; HEPATITIS C VIRUS; HUMAN; LIVER CELL; METHODOLOGY; PHYSIOLOGY; VIROLOGY;

ALGINATES; BATCH CELL CULTURE TECHNIQUES; BIOMIMETICS; CELL LINE; GLUCURONIC ACID; HEPACIVIRUS; HEPATOCYTES; HEXURONIC ACIDS; HUMANS; LIVER, ARTIFICIAL;

EID: 84871300312     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0139     Document Type: Article

References (56)

1. Malhi, H., Guicciardi, M.E., and Gores, G.J. Hepatocyte death: A clear and present danger. Physiol Rev 90, 1165, 2010.
2. Ramadori, G., Moriconi, F., Malik, I., and Dudas, J. Physiology and pathophysiology of liver inflammation, damage and repair. J Physiol Pharmacol 59 Suppl 1, 107, 2008.
3. Guguen-Guillouzo, C., and Guillouzo, A. General review on in vitro hepatocyte models and their applications. Methods Mol Biol 640, 1, 2010.
4. Olsavsky Goyak, K.M., Laurenzana, E.M., and Omiecinski, C.J. Hepatocyte differentiation. Methods Mol Biol 640, 115, 2010.
5. Hanada, S., Kayano, H., Jiang, J., Kojima, N., Miyajima, A., Sakoda, A., and Sakai, Y. Enhanced in vitro maturation of subcultivated fetal human hepatocytes in three dimensional culture using poly-L-lactic acid scaffolds in the presence of oncostatin M. Int J Artif Organs 26, 943, 2003.
6. Schmitmeier, S., Langsch, A., and Bader, A. A membranebased small-scale bioreactor for accelerated in vitro drug screenings with primary hepatocytes. Desalination 199, 258, 2006.
7. Ohashi, K., Yokoyama, T., Yamato, M., Kuge, H., Kanehiro, H., Tsutsumi, M., Amanuma, T., Iwata, H., Yang, J., Okano, T., and Nakajima, Y. Engineering functional two- and threedimensional liver systems in vivo using hepatic tissue sheets. Nat Med 13, 880, 2007.
8. Gao, Y., Jiang, H.C., Xu, J., Pan, S.H., and Li, Y.D. Microencapsulating hepatocytes. Transplant Proc 37, 4589, 2005.
9. Khalil, M., Shariat-Panahi, A., Tootle, R., Ryder, T., McCloskey, P., Roberts, E., Hodgson, H., and Selden, C. Human hepatocyte cell lines proliferating as cohesive spheroid colonies in alginate markedly upregulate both synthetic and detoxificatory liver function. J Hepatol 34, 68, 2001.
10. Seo, S.J., Akaike, T., Choi, Y.J., Shirakawa, M., Kang, I.K., and Cho, C.S. Alginate microcapsules prepared with xyloglucan as a synthetic extracellular matrix for hepatocyte attachment. Biomaterials 26, 3607, 2005.
11. Wang, N., Adams, G., Buttery, L., Falcone, F.H., and Stolnik, S. Alginate encapsulation technology supports embryonic stem cells differentiation into insulin-producing cells. J Biotechnol 144, 304, 2009.
12. Nicodemus, G.D., and Bryant, S.J. Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng Part B Rev 14, 149, 2008.
13. Dvir-Ginzberg, M., Elkayam, T., and Cohen, S. Induced differentiation and maturation of newborn liver cells into functional hepatic tissue in macroporous alginate scaffolds. FASEB J 22, 1440, 2008.
14. Miranda, J.P., Rodrigues, A., Tostoes, R.M., Leite, S., Zimmerman, H., Carrondo, M.J.T., and Alves, P.M. Extending hepatocyte functionality for drug-testing applications using high-viscosity alginate-encapsulated three-dimensional cultures in bioreactors. Tissue Eng Part C Methods 16, 1223, 2010.
15. Li, X., Liu, T., Song, K., Yao, L., Ge, D., Bao, C., Ma, X., and Cui, Z. Culture of neural stem cells in calcium alginate beads. Biotechnol Prog 22, 1683, 2006.
16. Zmora, S., Glicklis, R., and Cohen, S. Tailoring the pore architecture in 3-D alginate scaffolds by controlling the freezing regime during fabrication. Biomaterials 23, 4087, 2002.
17. David, B., Dore, E., Jaffrin, M.Y., and Legallais, C. Mass transfers in a fluidized bed bioreactor using alginate beads for a future bioartificial liver. Int J Artif Organs 27, 284, 2004.
18. Gautier, A., Carpentier, B., Dufresne, M., Dinh, Q.V., Paullier, P., and Legallais, C. Impact of alginate type and bead diameter on mass transfers and the metabolic activities of encapsulated C3A cells in bioartificial liver applications. Eur Cell Mater 21, 94, 2011.
19. Falasca, L., Miccheli, A., Sartori, E., Tomassini, A., and Devirgiliis, L.C. Hepatocytes entrapped in alginate gel beads and cultured in bioreactor: Rapid repolarization and reconstitution of adhesion areas. Cells Tissues Organs 168, 126, 2001.
20. Coward, S.M., Selden, C., Mantalaris, A., and Hodgson, H.J.F. Proliferation rates of HepG2 cells encapsulated in alginate are increased in a microgravity environment compared with static cultures. Artif Organs 29, 152, 2005.
21. Coward, S.M., Legallais, C., David, B., Thomas, M., Foo, Y., Mavri-Damelin, D., Hodgson, H.J., and Selden, C. Alginateencapsulated HepG2 cells in a fluidized bed bioreactor maintain function in human liver failure plasma. Artif Organs 33, 1117, 2009.
22. Dore, E., and Legallais, C. A new concept of bioartificial liver based on a fluidized bed bioreactor. Ther Apher 3, 264, 1999.
23. Kinasiewicz, A., Gautier, A., Lewinska, D., Bukowski, J., Legallais, C., and Werynski, A. Culture of C3A cells in alginate beads for fluidized bed Bioartificial liver. Transplant Proc 39, 2911, 2007.
24. Morch, Y.A., Donati, I., Strand, B.L., and Skjak-Braek, G. Effect of Ca2 +, Ba2 +, and Sr2 + on alginate microbeads. Biomacromolecules 7, 1471, 2006.
25. Murtas, S., Capuani, G., Dentini, M., Manetti, C., Masci, G., Massimi, M., Miccheli, A., and Crescenzi, V. Alginate beads as immobilization matrix for hepatocytes perfused in a bioreactor: A physico-chemical characterization. J Biomater Sci Polym Ed 16, 829, 2005.
26. Orive, G., Ponce, S., Hernandez, R.M., Gascon, A.R., Igartua, M., and Pedraz, J.L. Biocompatibility of microcapsules for cell immobilization elaborated with different type of alginates. Biomaterials 23, 3825, 2002.
27. Orive, G., Carcaboso, A.M., Hernandez, R.M., Gascon, A.R., and Pedraz, J.L. Biocompatibility evaluation of different alginates and alginate-based microcapsules. Biomacromolecules 6, 927, 2005.
28. Tam, S.K., Bilodeau, S., Dusseault, J., Langlois, G., Halle, J.P., and Yahia, L.H. Biocompatibility and physicochemical characteristics of alginate-polycation microcapsules. Acta Biomater 7, 1683, 2011.
29. Petruzzo, P., Cappai, A., Ruiu, G., Dessy, E., Rescigno, A., and Brotzu, G. Development of biocompatible barium alginate microcapsules. Transplant Proc 29, 2129, 1997.
30. Schneider, S., Feilen, P.J., Kraus, O., Haase, T., Sagban, T.A., Lehr, H.A., Beyer, J., Pommersheim, R., and Weber, M.M. Biocompatibility of alginates for grafting: Impact of alginate molecular weight. Artif Cells Blood Substit Immobil Biotechnol 31, 383, 2003.
31. Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z.J., Murthy, K., Habermann, A., Krausslich, H.G., Mizokami, M., Bartenschlager, R., and Liang, T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11, 791, 2005.
32. Zhong, J., Gastaminza, P., Cheng, G.F., Kapadia, S., Kato, T., Burton, D.R., Wieland, S.F., Uprichard, S.L., Wakita, T., and Chisari, F.V. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 102, 9294, 2005.
33. Défarge, C. Apports du cryo-microscope électronique a balayage et du microscope électronique a balayage haute résolution a l'étude des matieres organiques et des relations organo- minérales naturelles. Exemple des sédiments microbiens actuels. C R Acad Sci Paris Sér IIa 324, 553, 1997.
34. Gomes, J.F.P.S., Rocha, S., Pereira, M.D., Peres, I., Moreno, S., Toca-Herrera, J., and Coelho, M.A.N. Lipid/particle assemblies based on maltodextrin-gum arabic core as biocarriers. Colloids Surf B Biointerfaces 76, 449, 2010.
35. Kinasiewicz, A., Gautier, A., Lewinska, D., Smietanka, A., Legallais, C., and Werynski, A. Three-dimensional growth of human hepatoma C3A cells within alginate beads for fluidized bioartificial liver. Int J Artif Organs 31, 340, 2008.
36. Khattak, S.F., Spatara, M., Roberts, L., and Roberts, S.C. Application of colorimetric assays to assess viability, growth and metabolism of hydrogel-encapsulated cells. Biotechnol Lett 28, 1361, 2006.
37. Lv, G., Zhao, L., Zhang, A., Du, W., Chen, Y., Yu, C., Pan, X., Zhang, Y., Song, T., Xu, J., Chen, Y., and Li, L. Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs. Biotechnol Bioeng 108, 2229, 2011.
38. Tostoes, R.M., Leite, S.B., Miranda, J.P., Sousa, M., Wang, D.I., Carrondo, M.J., and Alves, P.M. Perfusion of 3D encapsulated hepatocytes - a synergistic effect enhancing longterm functionality in bioreactors. Biotechnol Bioeng 108, 41, 2011.
39. Yang, Q., Liu, F., Pan, X.P., Lv, G., Zhang, A., Yu, C.B., and Li, L. Fluidized-bed bioartificial liver assist devices (BLADs) based on microencapsulated primary porcine hepatocytes have risk of porcine endogenous retroviruses transmission. Hepatol Int 4, 757, 2010.
40. Bazou, D., Coakley, W.T., Hayes, A.J., and Jackson, S.K. Long-term viability and proliferation of alginate-encapsulated 3-D HepG2 aggregates formed in an ultrasound trap. Toxicol In Vitro 22, 1321, 2008.
41. Lan, S.F., Safiejko-Mroczka, B., and Starly, B. Long-term cultivation of HepG2 liver cells encapsulated in alginate hydrogels: A study of cell viability, morphology and drug metabolism. Toxicol In Vitro 24, 1314, 2010.
42. Shirai, Y., and Hashimoto, K. Production of monoclonal antibody by hybridoma cells entrapped by alginate gel in a medium containing divalent cations and glucose-1-phosphate. J Ferment Bioeng 68, 264, 1989.
43. Cheng, N., Wauthier, E., and Reid, L.M. Mature human hepatocytes from ex vivo differentiation of alginate-encapsulated hepatoblasts. Tissue Eng Part A 14, 1, 2008.
44. Abu-Absi, S.F., Friend, J.R., Hansen, L.K., and Hu, W.S. Structural polarity and functional bile canaliculi in rat hepatocyte spheroids. Exp Cell Res 274, 56, 2002.
45. Lee, J., Cuddihy, M.J., Cater, G.M., and Kotov, N.A. Engineering liver tissue spheroids with inverted colloidal crystal scaffolds. Biomaterials 30, 4687, 2009.
46. Choi, S., Sainz B., Jr., Corcoran, P., Uprichard, S., and Jeong, H. Characterization of increased drug metabolism activity in dimethyl sulfoxide (DMSO)-treated Huh7 hepatoma cells. Xenobiotica 39, 205, 2009.
47. Anzenbacher, P., and Anzenbacherová, E. Cytochromes P450 and metabolism of xenobiotics. Cell Mol Life Sci 58, 737, 2001.
48. Kim, Y., and Rajagopalan, P. 3D hepatic cultures simultaneously maintain primary hepatocyte and liver sinusoidal endothelial cell phenotypes. Plos One 5, 15456, 2010.
49. Raucy, J.L., Mueller, L., Duan, K., Allen, S.W., Strom, S., and Lasker, J.M. Expression and induction of CYP2CP450 enzymes in primary cultures of human Hepatocytes. J Pharmacol Exp Ther 302, 475, 2002.
50. Richert, L., Liguori, M.J., Abadie, C., Heyd, B., Mantion, G., Halkic, N., and Waring, J.F. Gene expression in human hepatocytes in suspension after isolation is similar to the liver of origin, is not affected by hepatocyte cold storage and cryopreservation, but is strongly changed after hepatocyte plating. Drug Metab Dispos 34, 870, 2006.
51. Sainz, B., TenCate, V., and Uprichard, S.L. Three-dimensional Huh7 cell culture system for the study of Hepatitis C virus infection. Virol J 6, 103, 2009.
52. Murakami, K., Ishii, K., Ishihara, Y., Yoshizaki, S., Tanaka, K., Gotoh, Y., Aizaki, H., Kohara, M., Yoshioka, H., Mori, Y., Manabe, N., Shoji, I., Sata, T., Bartenschlager, R., Matsuura, Y., Miyamura, T., and Suzuki, T. Production of infectious hepatitis C virus particles in three-dimensional cultures of the cell line carrying the genome-length dicistronic viral RNA of genotype 1b. Virology 351, 381, 2006.
53. Evans, M.J., von Hahn, T., Tscherne, D.M., Syder, A.J., Panis, M., Wolk, B., Hatziioannou, T., McKeating, J.A., Bieniasz, P.D., and Rice, C.M. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446, 801, 2007.
54. Ploss, A., Evans, M.J., Gaysinskaya, V.A., Panis, M., You, H.N., de Jong, Y.P., and Rice, C.M. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457, 882, 2009.
55. Sainz, B., Jr., Barretto, N., Martin, D.N., Hiraga, N., Imamura, M., Hussain, S., Marsh, K.A., Yu, X., Chayama, K., Alrefai, W.A., and Uprichard, S.L. Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. Nat Med 18, 281, 2012.
56. Liu, S., Yang, W., Shen, L., Turner, J.R., Coyne, C.B., and Wang, T. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J Virol 83, 2011, 2009.